JP Stock MarketDetailed Quotes

Astellas Pharma (4503)

Watchlist
  • 2367.5
  • -9.5-0.40%
20min DelayMarket Closed May 14 15:30 JST
4.28TMarket Cap14.59P/E (Static)

Astellas Pharma (4503) Key Financial Indicators

4503 Earnings per Share (EPS)

According to the latest financial report of Astellas Pharma, the latest earnings per share (TTM) for the company is 38.11. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: JPY

Quarterly

Loading...

4503 Free Cash Flow (FCF)

Interested in knowing about Astellas Pharma's free cash flow? The latest report shows it as 58.39B. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: JPY

Quarterly

Loading...

4503 Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Astellas Pharma shows that the company's current ratio is 1.17, indicating healthy liquidity.

Currency: JPY

Quarterly

Loading...

4503 Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Astellas Pharma, the quick ratio is 0.85, indicating that the company can meet its short-term debt obligations.

Currency: JPY

Quarterly

Loading...

4503 Return on Equity (ROE)

Want to learn more about the financial health of Astellas Pharma? The latest ROE figure is -2.15%, indicating that the company has stable profitability.

Currency: JPY

Quarterly

Loading...

4503 Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Astellas Pharma, the total asset return on investment (ROA) is -0.96%.

Currency: JPY

Quarterly

Loading...

4503 Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Astellas Pharma's latest financial report to see how their gross margin is doing - currently at 81.25%.

Currency: JPY

Quarterly

Loading...

4503 Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Astellas Pharma, the net profit margin is 13.53%, which is a good sign for its profitability.

Currency: JPY

Quarterly

Loading...

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More